Ramipril and Cardiovascular Outcomes in Patients on Maintenance Hemodialysis
Ramipril did not reduce the risk of major cardiovascular events in patients on maintenance hemodialysis. The study was a prospective, randomized, open-label, blinded endpoint, parallel, multicenter trial.
